Sapiens International (SPNS) has had the highest return since January 1, 2025 by a US stock with a market cap of $1B+, returning 53,426.8%.
| ASSET | % RETURN |
|---|---|
Sapiens International (SPNS) | 53,426.82% |
Regencell Bioscience (RGC) | 14,061.68% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 9,155.81% |
Abivax SA American Depositary Shares (ABVX) | 1,469.2% |
Diginex Limited Ordinary Shares (DGNX) | 1,064.32% |
Palvella Therapeutics (PVLA) | 728.94% |
Cidara Therapeutics (CDTX) | 712.8% |
Celcuity LLC (CELC) | 650.08% |
Nanobiotix (NBTX) | 610.61% |
Terns Pharmaceuticals (TERN) | 606.03% |
Newegg Commerce (NEGG) | 598.63% |
Hycroft Mining (HYMC) | 579.65% |
Sandisk (SNDK) | 525.96% |
TMC the metals (TMC) | 507.02% |
Almonty Industries Inc Common Shares (ALM) | 479.86% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 475.1% |
Americas Silver (USAS) | 460% |
Nutex Health (NUTX) | 420.89% |
Olema Pharmaceuticals (OLMA) | 420.44% |
GRAIL, LLC (GRAL) | 395.59% |
Cogent Biosciences (COGT) | 379.75% |
Resolute Holdings Management (RHLD) | 379.31% |
EchoStar (SATS) | 343.34% |
Aris Mining (ARMN) | 340.85% |
Aura Minerals Inc Common Shares (AUGO) | 337.25% |
